Insight Molecular Diagnostics Inc. (IMDX) › Capital ExpendituresInsight Molecular Diagnostics Inc. (IMDX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $9.0K2015: $500.0K2016: $106.0K2017: $91.0K2018: $31.0K2019: $918.0K2020: $1.23M2021: $2.25M2022: $4.34M2023: $281.0K2024: $516.0K2025: $3.19M$3.19M2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$3.19M+517.2%2024$516.0K+83.6%2023$281.0K-93.5%2022$4.34M+93.1%2021$2.25M+83.1%2020$1.23M+33.7%2019$918.0K+2861.3%2018$31.0K-65.9%2017$91.0K-14.2%2016$106.0K-78.8%2015$500.0K+5455.6%2014$9.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share